Hepatitis B virus X protein induces epithelial–mesenchymal transition by repressing E-cadherin expression via upregulation of E12/E47

Journal of General Virology

Volumn 97, Issue 1, 2016, Pages 134-143

  Kim, Soo Shin ^a   Yeom, Sujeong ^a   Kwak, Juri ^a   Ahn, Hyung Jun ^a   Jang, Kyung Lib ^a  

^a Pusan National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRONECTIN; HEPATITIS B VIRUS X PROTEIN; NERVE CELL ADHESION MOLECULE; PLAKOGLOBIN; PROTEASOME; SMALL INTERFERING RNA; UVOMORULIN; VIMENTIN; CADHERIN; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR 3;

ARTICLE; CELL MIGRATION; E BOX ELEMENT; ECTOPIC EXPRESSION; EPITHELIAL MESENCHYMAL TRANSITION; GENE REPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; LIVER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN MOTIF; PROTEIN STRUCTURE; REPLICON; UPREGULATION; ANTAGONISTS AND INHIBITORS; CELL LINE; DRUG EFFECTS; GENE EXPRESSION REGULATION; HEPATITIS B VIRUS; HOST PATHOGEN INTERACTION; METABOLISM; PHYSIOLOGY;

CADHERINS; CELL LINE; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION; HEPATITIS B VIRUS; HEPATOCYTES; HOST-PATHOGEN INTERACTIONS; HUMANS; TRANS-ACTIVATORS; TRANSCRIPTION FACTOR 3;

EID: 84957543163     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/jgv.0.000324     Document Type: Article

References (43)

1. Arzumanyan, A., Friedman, T., Kotei, E., Ng, I. O., Lian, Z. & Feitelson, M. A. (2012). Epigenetic repression of E-cadherin expression by hepatitis B virus X antigen in liver cancer. Oncogene 31, 563–572.
2. Batlle, E., Sancho, E., Francí, C., Domínguez, D., Monfar, M., Baulida, J. & García De Herreros, A. (2000). The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol 2, 84–89.
3. Birchmeier, W. & Behrens, J. (1994). Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasiveness. Biochim Biophys Acta 1198, 11–26.
4. Blattler, A. & Farnham, P. J. (2013). Cross-talk between site-specific transcription factors and DNA methylation states. J Biol Chem 288, 34287–34294.
5. Cha, M. Y., Ryu, D. K., Jung, H. S., Chang, H. E. & Ryu, W. S. (2009). Stimulation of hepatitis B virus genome replication by HBx is linked to both nuclear and cytoplasmic HBx expression. J Gen Virol 90, 978–986.
6. Chan, C. F., Yau, T. O., Jin, D. Y., Wong, C. M., Fan, S. T. & Ng, I. O. (2004). Evaluation of nuclear factor kB, urokinase-type plasminogen activator, and HBx and their clinicopathological significance in hepatocellular carcinoma. Clin Cancer Res 10, 4140–4149.
7. Henthorn, P., Kiledjian, M. & Kadesch, T. (1990). Two distinct transcription factors that bind the immunoglobulin enhancer mE5/ k2 motif. Science 247, 467–470.
8. Herman, J. G., Graff, J. R., Myöhänen, S., Nelkin, B. D. & Baylin, S. B. (1996). Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A 93, 9821–9826.
9. Hirohashi, S. & Kanai, Y. (2003). Cell adhesion system and human cancer morphogenesis. Cancer Sci 94, 575–581.
10. Jung, J. K., Arora, P., Pagano, J. S. & Jang, K. L. (2007). Expression of DNA methyltransferase 1 is activated by hepatitis B virus X protein via a regulatory circuit involving the p16INK4a-cyclin D1-CDK 4/6- pRb-E2F1 pathway. Cancer Res 67, 5771–5778.
11. Kalluri, R. & Weinberg, R. A. (2009). The basics of epithelial– mesenchymal transition. J Clin Invest 119, 1420–1428.
12. Kanai, Y., Ushijima, S., Hui, A. M., Ochiai, A., Tsuda, H., Sakamoto, M. & Hirohashi, S. (1997). The E-cadherin gene is silenced by CpG methylation in human hepatocellular carcinomas. Int J Cancer 71, 355–359.
13. Kang, Y. & Massagué, J. (2004). Epithelial–mesenchymal transitions: twist in development and metastasis. Cell 118, 277–279.
14. Kawanishi, J., Kato, J., Sasaki, K., Fujii, S., Watanabe, N. & Niitsu, Y. (1995). Loss of E-cadherin-dependent cell–cell adhesion due to mutation of the b-catenin gene in a human cancer cell line, HSC- 39.Mol Cell Biol 15, 1175–1181.
15. Kwun, H. J. & Jang, K. L. (2004). Natural variants of hepatitis B virus X protein have differential effects on the expression of cyclin-dependent kinase inhibitor p21 gene. Nucleic Acids Res 32, 2202–2213.
16. Lara-Pezzi, E., Majano, P. L., Yáñez-Mó, M., Gómez-Gonzalo, M., Carretero, M., Moreno-Otero, R., Sánchez-Madrid, F. & López- Cabrera, M. (2001a). Effect of the hepatitis B virus HBx protein on integrin-mediated adhesion to and migration on extracellular matrix. J Hepatol 34, 409–415.
17. Lara-Pezzi, E., Roche, S., Andrisani, O. M., Sánchez-Madrid, F. & López-Cabrera, M. (2001b). The hepatitis B virus HBx protein induces adherens junction disruption in a src-dependent manner. Oncogene 20, 3323–3331.
18. Lara-Pezzi, E., Serrador, J. M., Montoya, M. C., Zamora, D., Yáñez-Mó, M., Carretero, M., Furthmayr, H., Sá nchez-Madrid, F. & López-Cabrera, M. (2001c). The hepatitis B virus X protein (HBx) induces a migratory phenotype in a CD44-dependent manner: possible role of HBx in invasion and metastasis. Hepatology 33, 1270–1281.
19. Le Bras, G. F., Taubenslag, K. J. & Andl, C. D. (2012). The regulation of cell–cell adhesion during epithelial–mesenchymal transition, motility and tumor progression. Cell Adhes Migr 6, 365–373.
20. Lee, S., Lee, H. J., Kim, J. H., Lee, H. S., Jang, J. J. & Kang, G. H. (2003). Aberrant CpG island hypermethylation along multistep hepatocarcinogenesis. Am J Pathol 163, 1371–1378.
21. Lee, J. O., Kwun, H. J., Jung, J. K., Choi, K. H., Min, D. S. & Jang, K. L. (2005). Hepatitis B virus X protein represses E-cadherin expression via activation of DNA methyltransferase 1.Oncogene 24, 6617–6625.
22. Leonard, M., Chan, Y. & Menko, A. S. (2008). Identification of a novel intermediate filament-linked N-cadherin/c-catenin complex involved in the establishment of the cytoarchitecture of differentiated lens fiber cells. Dev Biol 319, 298–308.
23. Lin, Y., Wu, Y., Li, J., Dong, C., Ye, X., Chi, Y. I., Evers, B. M. & Zhou, B. P. (2010). The SNAG domain of Snail1 functions as a molecular hook for recruiting lysine-specific demethylase 1.EMBO J 29, 1803–1816.
24. Liu, J., Lian, Z., Han, S., Waye, M. M., Wang, H., Wu, M. C., Wu, K., Ding, J., Arbuthnot, P. & other authors (2006). Downregulation of E-cadherin by hepatitis B virus X antigen in hepatocellullar carcinoma. Oncogene 25, 1008–1017.
25. Liu, H., Xu, L., He, H., Zhu, Y., Liu, J., Wang, S., Chen, L., Wu, Q., Xu, J. & Gu, J. (2012). Hepatitis B virus X protein promotes hepatoma cell invasion and metastasis by stabilizing Snail protein. Cancer Sci 103, 2072–2081.
26. Neuveut, C., Wei, Y. & Buendia, M. A. (2010). Mechanisms of HBVrelated hepatocarcinogenesis. J Hepatol 52, 594–604.
27. Park, B. J., Kang, J. W., Lee, S. W., Choi, S. J., Shin, Y. K., Ahn, Y. H., Choi, Y. H., Choi, D., Lee, K. S. & Kim, S. (2005). The haploinsufficient tumor suppressor p18 upregulates p53 via interactions with ATM/ ATR. Cell 120, 209–221.
28. Paterlini, P., Poussin, K., Kew, M., Franco, D. & Brechot, C. (1995). Selective accumulation of the X transcript of hepatitis B virus in patients negative for hepatitis B surface antigen with hepatocellular carcinoma. Hepatology 21, 313–321.
29. Perez-Moreno, M. A., Locascio, A., Rodrigo, I., Dhondt, G., Portillo, F., Nieto, M. A. & Cano, A. (2001). A new role for E12/E47 in the repression of E-cadherin expression and epithelial–mesenchymal transitions. J Biol Chem 276, 27424–27431.
30. Quong, M. W., Romanow, W. J. & Murre, C. (2002). E protein function in lymphocyte development. Annu Rev Immunol 20, 301–322.
31. Rodriguez, L. G., Wu, X. & Guan, J. L. (2005). Wound-healing assay. Methods Mol Biol 294, 23–29.
32. Sells, M. A., Chen, M. L. & Acs, G. (1987). Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA. Proc Natl Acad Sci U S A 84, 1005–1009.
33. Tania, M., Khan, M. A. & Fu, J. (2014). Epithelial to mesenchymal transition inducing transcription factors and metastatic cancer. Tumour Biol 35, 7335–7342.
34. Teng, Y. & Li, X. (2014). The roles of HLH transcription factors in epithelial mesenchymal transition and multiple molecular mechanisms. Clin Exp Metastasis 31, 367–377.
35. Tian, Y., Yang, W., Song, J., Wu, Y. & Ni, B. (2013). Hepatitis B virus X protein-induced aberrant epigenetic modifications contributing to human hepatocellular carcinoma pathogenesis. Mol Cell Biol 33, 2810–2816.
36. van Roy, F. & Berx, G. (2008). The cell–cell adhesion molecule E-cadherin. Cell Mol Life Sci 65, 3756–3788.
37. Watabe, M., Nagafuchi, A., Tsukita, S. & Takeichi, M. (1994). Induction of polarized cell–cell association and retardation of growth by activation of the E-cadherin–catenin adhesion system in a dispersed carcinoma line. J Cell Biol 127, 247–256.
38. Wei, Y., Van Nhieu, J. T., Prigent, S., Srivatanakul, P., Tiollais, P. & Buendia, M. A. (2002). Altered expression of E-cadherin in hepatocellular carcinoma: correlations with genetic alterations, bcatenin expression, and clinical features. Hepatology 36, 692–701.
39. Wells, A., Yates, C. & Shepard, C. R. (2008). E-cadherin as an indicator of mesenchymal to epithelial reverting transitions during the metastatic seeding of disseminated carcinomas. Clin Exp Metastasis 25, 621–628.
40. Woo, Y. J. & Jang, K. L. (2012). All-trans retinoic acid activates E-cadherin expression via promoter hypomethylation in the human colon carcinoma HCT116 cells. Biochem Biophys Res Commun 425, 944–949.
41. Xu, C., Zhou, W., Wang, Y. & Qiao, L. (2014). Hepatitis B virusinduced hepatocellular carcinoma. Cancer Lett 345, 216–222.
42. Yang, B., Guo, M., Herman, J. G. & Clark, D. P. (2003). Aberrant promoter methylation profiles of tumor suppressor genes in hepatocellular carcinoma. Am J Pathol 163, 1101–1107.
43. Yoshiura, K., Kanai, Y., Ochiai, A., Shimoyama, Y., Sugimura, T. & Hirohashi, S. (1995). Silencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomas. Proc Natl Acad Sci U S A 92, 7416–7419.